DK0760677T3 - Farmaceutisk præparat omfattende glucagon - Google Patents
Farmaceutisk præparat omfattende glucagonInfo
- Publication number
- DK0760677T3 DK0760677T3 DK95919980T DK95919980T DK0760677T3 DK 0760677 T3 DK0760677 T3 DK 0760677T3 DK 95919980 T DK95919980 T DK 95919980T DK 95919980 T DK95919980 T DK 95919980T DK 0760677 T3 DK0760677 T3 DK 0760677T3
- Authority
- DK
- Denmark
- Prior art keywords
- glucagon
- pharmaceutical composition
- preparation
- dipeptide
- excipient
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/26—Glucagons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DK59094 | 1994-05-26 | ||
PCT/DK1995/000208 WO1995032730A1 (en) | 1994-05-26 | 1995-05-26 | A pharmaceutical preparation comprising glucagon |
Publications (1)
Publication Number | Publication Date |
---|---|
DK0760677T3 true DK0760677T3 (da) | 2001-12-31 |
Family
ID=8095292
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK95919980T DK0760677T3 (da) | 1994-05-26 | 1995-05-26 | Farmaceutisk præparat omfattende glucagon |
Country Status (12)
Country | Link |
---|---|
US (1) | US5652216A (da) |
EP (1) | EP0760677B1 (da) |
JP (1) | JP3295430B2 (da) |
AT (1) | ATE205090T1 (da) |
AU (1) | AU694229B2 (da) |
CA (1) | CA2191317A1 (da) |
DE (1) | DE69522562T2 (da) |
DK (1) | DK0760677T3 (da) |
ES (1) | ES2163511T3 (da) |
FI (1) | FI964682A (da) |
NO (1) | NO965012D0 (da) |
WO (1) | WO1995032730A1 (da) |
Families Citing this family (63)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1094757C (zh) | 1996-07-24 | 2002-11-27 | 沃尼尔·朗伯公司 | 用于治疗疼痛的异丁基γ-氨基丁酸及其衍生物 |
US6384016B1 (en) * | 1998-03-13 | 2002-05-07 | Novo Nordisk A/S | Stabilized aqueous peptide solutions |
US6458924B2 (en) | 1996-08-30 | 2002-10-01 | Novo Nordisk A/S | Derivatives of GLP-1 analogs |
US7235627B2 (en) | 1996-08-30 | 2007-06-26 | Novo Nordisk A/S | Derivatives of GLP-1 analogs |
JP4072319B2 (ja) * | 1998-03-13 | 2008-04-09 | ノヴォ ノルディスク アクティーゼルスカブ | 安定化水溶性ペプチド溶液 |
JP2002193830A (ja) * | 1998-10-19 | 2002-07-10 | High Chem Co Ltd | 経鼻投与用医薬製剤 |
GB9930882D0 (en) * | 1999-12-30 | 2000-02-23 | Nps Allelix Corp | GLP-2 formulations |
DE10022092A1 (de) * | 2000-05-08 | 2001-11-15 | Aventis Behring Gmbh | Stabilisiertes Protein-Präparat und Verfahren zu seiner Herstellung |
DE60224284T2 (de) * | 2001-06-28 | 2008-12-18 | Novo Nordisk A/S | Stabile formulierung von modifiziertem glp-1 |
CN102940879B (zh) * | 2003-06-03 | 2017-06-06 | 诺沃挪第克公司 | 稳定化的药物肽组合物 |
WO2004105790A1 (en) * | 2003-06-03 | 2004-12-09 | Novo Nordisk A/S | Stabilized pharmaceutical peptide compositions |
US7591801B2 (en) | 2004-02-26 | 2009-09-22 | Dexcom, Inc. | Integrated delivery device for continuous glucose sensor |
US20050027005A1 (en) * | 2003-08-02 | 2005-02-03 | Matthias Boldt | Nutrient compositions and methods for sustenance and promotion of positive metabolic energy levels in a targeted manner |
BRPI0413276B8 (pt) | 2003-08-05 | 2021-05-25 | Novo Nordisk As | derivado de insulina, complexo de zinco do mesmo, e, composição farmacêutica |
US7141544B2 (en) * | 2003-10-10 | 2006-11-28 | Baxter International, Inc. | Stabilization of pharmaceutical protein formulations with small peptides |
CN104826116A (zh) * | 2003-11-20 | 2015-08-12 | 诺沃挪第克公司 | 对于生产和用于注射装置中是最佳的含有丙二醇的肽制剂 |
EP1752146A4 (en) * | 2004-05-19 | 2007-10-10 | Ajinomoto Kk | THERAPEUTIC AGENT AGAINST DIABETES |
ES2442223T3 (es) * | 2004-08-31 | 2014-02-10 | Novo Nordisk A/S | Uso de tris(hidroximetil) aminometano para la estabilización de péptidos, polipéptidos y proteínas |
CN106137952B (zh) * | 2004-11-12 | 2020-11-17 | 诺和诺德公司 | 促胰岛素肽的稳定制剂 |
EP2505593A1 (en) | 2005-12-28 | 2012-10-03 | Novo Nordisk A/S | Compositions comprising an acylated insulin and zinc and method of making the said compositions |
US20080286340A1 (en) * | 2007-05-16 | 2008-11-20 | Sven-Borje Andersson | Buffered nicotine containing products |
US20080286341A1 (en) * | 2007-05-16 | 2008-11-20 | Sven-Borje Andersson | Buffered coated nicotine containing products |
WO2008152106A1 (en) | 2007-06-13 | 2008-12-18 | Novo Nordisk A/S | Pharmaceutical formulation comprising an insulin derivative |
EP4159114B1 (en) | 2007-10-09 | 2024-04-10 | DexCom, Inc. | Integrated insulin delivery system with continuous glucose sensor |
EP2203741B1 (en) | 2007-10-25 | 2023-05-10 | Dexcom, Inc. | Systems and methods for processing sensor data |
ES2607003T3 (es) | 2008-10-30 | 2017-03-28 | Novo Nordisk A/S | Tratamiento de diabetes mellitus utilizando inyecciones de insulina con una frecuencia de inyección inferior a la diaria |
EP3466438A1 (en) | 2009-08-03 | 2019-04-10 | Incube Labs, Llc | Swallowable capsule and method for stimulating incretin production within the intestinal tract |
US9610329B2 (en) * | 2009-10-22 | 2017-04-04 | Albireo Pharma, Inc. | Stabilized glucagon solutions |
EP2490708B1 (en) | 2009-10-22 | 2013-03-27 | Biodel Inc. | Stabilized glucagon solutions |
US20110097386A1 (en) * | 2009-10-22 | 2011-04-28 | Biodel, Inc. | Stabilized glucagon solutions |
US8562589B2 (en) | 2009-12-24 | 2013-10-22 | Rani Therapeutics, Llc | Swallowable drug delivery device and method of delivery |
WO2012012460A1 (en) * | 2010-07-19 | 2012-01-26 | Xeris Pharmaceuticals, Inc. | Stable glucagon formulations for the treatment of hypoglycemia |
RU2013123515A (ru) | 2010-10-27 | 2014-12-10 | Ново Нордиск А/С | Лечение сахарного диабета с помощью инъекций инсулина, вводимых с различными интервалами |
US9629799B2 (en) | 2010-12-23 | 2017-04-25 | Rani Therapeutics, Llc | Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device |
US8980822B2 (en) | 2010-12-23 | 2015-03-17 | Rani Therapeutics, Llc | Therapeutic agent preparations comprising pramlintide for delivery into a lumen of the intestinal tract using a swallowable drug delivery device |
US10639272B2 (en) | 2010-12-23 | 2020-05-05 | Rani Therapeutics, Llc | Methods for delivering etanercept preparations into a lumen of the intestinal tract using a swallowable drug delivery device |
US9402807B2 (en) | 2010-12-23 | 2016-08-02 | Rani Therapeutics, Llc | Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device |
US8734429B2 (en) | 2010-12-23 | 2014-05-27 | Rani Therapeutics, Llc | Device, system and methods for the oral delivery of therapeutic compounds |
US9861683B2 (en) | 2010-12-23 | 2018-01-09 | Rani Therapeutics, Llc | Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device |
US9259386B2 (en) | 2010-12-23 | 2016-02-16 | Rani Therapeutics, Llc | Therapeutic preparation comprising somatostatin or somatostatin analogoue for delivery into a lumen of the intestinal tract using a swallowable drug delivery device |
US8846040B2 (en) | 2010-12-23 | 2014-09-30 | Rani Therapeutics, Llc | Therapeutic agent preparations comprising etanercept for delivery into a lumen of the intestinal tract using a swallowable drug delivery device |
US9283179B2 (en) | 2010-12-23 | 2016-03-15 | Rani Therapeutics, Llc | GnRH preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device |
US9415004B2 (en) | 2010-12-23 | 2016-08-16 | Rani Therapeutics, Llc | Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device |
US9284367B2 (en) | 2010-12-23 | 2016-03-15 | Rani Therapeutics, Llc | Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device |
US8809269B2 (en) | 2010-12-23 | 2014-08-19 | Rani Therapeutics, Llc | Therapeutic agent preparations comprising insulin for delivery into a lumen of the intestinal tract using a swallowable drug delivery device |
US9402806B2 (en) | 2010-12-23 | 2016-08-02 | Rani Therapeutics, Llc | Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device |
US8969293B2 (en) | 2010-12-23 | 2015-03-03 | Rani Therapeutics, Llc | Therapeutic agent preparations comprising exenatide for delivery into a lumen of the intestinal tract using a swallowable drug delivery device |
CN105853348B (zh) | 2011-03-10 | 2019-08-30 | Xeris药物公司 | 肠胃外注射用稳定溶液 |
KR102007057B1 (ko) | 2011-10-31 | 2019-08-02 | 엑스에리스 파머수티클스, 인크. | 당뇨병 치료를 위한 제형물 |
WO2013086292A1 (en) * | 2011-12-09 | 2013-06-13 | Enject, Inc. | Glucagon formulations |
US9125805B2 (en) | 2012-06-27 | 2015-09-08 | Xeris Pharmaceuticals, Inc. | Stable formulations for parenteral injection of small molecule drugs |
US9018162B2 (en) | 2013-02-06 | 2015-04-28 | Xeris Pharmaceuticals, Inc. | Methods for rapidly treating severe hypoglycemia |
US10137172B2 (en) | 2013-04-30 | 2018-11-27 | Novo Nordisk A/S | Administration regime |
ES2708996T3 (es) * | 2013-08-22 | 2019-04-12 | Zp Opco Inc | Formulaciones estables de péptido glucagón |
US9782344B2 (en) * | 2013-08-22 | 2017-10-10 | Zp Opco, Inc. | Stable glucagon peptide formulations |
EP3185932A1 (en) | 2014-08-06 | 2017-07-05 | Xeris Pharmaceuticals, Inc. | Syringes, kits, and methods for intracutaneous and/or subcutaneous injection of pastes |
US9649364B2 (en) | 2015-09-25 | 2017-05-16 | Xeris Pharmaceuticals, Inc. | Methods for producing stable therapeutic formulations in aprotic polar solvents |
AU2016287843B2 (en) * | 2015-07-02 | 2021-06-17 | Rani Therapeutics, Llc | Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device |
US11590205B2 (en) | 2015-09-25 | 2023-02-28 | Xeris Pharmaceuticals, Inc. | Methods for producing stable therapeutic glucagon formulations in aprotic polar solvents |
JP7299166B2 (ja) | 2017-06-02 | 2023-06-27 | ゼリス ファーマシューティカルズ インコーポレイテッド | 沈殿抵抗性低分子薬物製剤 |
TWI762706B (zh) | 2017-08-24 | 2022-05-01 | 丹麥商諾佛 儂迪克股份有限公司 | Glp-1組成物及其用途 |
US10335464B1 (en) | 2018-06-26 | 2019-07-02 | Novo Nordisk A/S | Device for titrating basal insulin |
WO2021144476A1 (en) | 2020-02-18 | 2021-07-22 | Novo Nordisk A/S | Pharmaceutical formulations |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK27885A (da) * | 1985-01-22 | 1986-07-23 | Novo Industri As | Fremstilling af peptider |
US5023088A (en) * | 1987-06-25 | 1991-06-11 | Alza Corporation | Multi-unit delivery system |
US5059587A (en) * | 1987-08-03 | 1991-10-22 | Toyo Jozo Company, Ltd. | Physiologically active peptide composition for nasal administration |
ES2044941T5 (es) * | 1987-08-21 | 1999-02-16 | Mallinckrodt Group Inc | Estabilizador de hormonas promotoras del crecimiento. |
DK204791D0 (da) * | 1991-12-20 | 1991-12-20 | Novo Nordisk As | Hidtil ukendt farmaceutisk praeparat |
-
1994
- 1994-07-15 US US08/275,855 patent/US5652216A/en not_active Expired - Lifetime
-
1995
- 1995-05-26 AU AU25606/95A patent/AU694229B2/en not_active Ceased
- 1995-05-26 DE DE69522562T patent/DE69522562T2/de not_active Expired - Lifetime
- 1995-05-26 WO PCT/DK1995/000208 patent/WO1995032730A1/en active IP Right Grant
- 1995-05-26 CA CA002191317A patent/CA2191317A1/en not_active Abandoned
- 1995-05-26 ES ES95919980T patent/ES2163511T3/es not_active Expired - Lifetime
- 1995-05-26 AT AT95919980T patent/ATE205090T1/de not_active IP Right Cessation
- 1995-05-26 EP EP95919980A patent/EP0760677B1/en not_active Expired - Lifetime
- 1995-05-26 JP JP50018796A patent/JP3295430B2/ja not_active Expired - Fee Related
- 1995-05-26 DK DK95919980T patent/DK0760677T3/da active
-
1996
- 1996-11-25 NO NO965012A patent/NO965012D0/no not_active Application Discontinuation
- 1996-11-25 FI FI964682A patent/FI964682A/fi unknown
Also Published As
Publication number | Publication date |
---|---|
DE69522562T2 (de) | 2002-07-11 |
AU694229B2 (en) | 1998-07-16 |
ATE205090T1 (de) | 2001-09-15 |
NO965012L (no) | 1996-11-25 |
EP0760677B1 (en) | 2001-09-05 |
JPH10500696A (ja) | 1998-01-20 |
FI964682A0 (fi) | 1996-11-25 |
CA2191317A1 (en) | 1995-12-07 |
DE69522562D1 (de) | 2001-10-11 |
WO1995032730A1 (en) | 1995-12-07 |
ES2163511T3 (es) | 2002-02-01 |
EP0760677A1 (en) | 1997-03-12 |
US5652216A (en) | 1997-07-29 |
JP3295430B2 (ja) | 2002-06-24 |
AU2560695A (en) | 1995-12-21 |
FI964682A (fi) | 1997-01-20 |
NO965012D0 (no) | 1996-11-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK0760677T3 (da) | Farmaceutisk præparat omfattende glucagon | |
NO971889L (no) | Forbindelser og sammensetninger for levering av aktive midler | |
HUT51254A (en) | Process for producing amino acid derivatives and pharmaceutical compositions comprising same as active ingredient | |
SE8804629A (da) | ||
ITRM910922A1 (it) | Composizione farmaceutica anticefalalgica per somministrazione endonasale, procedimento per prepararla e suo impiego terapeutico | |
HUP9701059A2 (hu) | Stronciumsók alkalmazása ízületi bántalmak kezelésére alkalmas gyógyszerkészítmények előállítására | |
NZ232695A (en) | Amino acid derivatives and pharmaceutical compositions thereof | |
DE69727956D1 (de) | Pharmazeutische zubereitungen zur verminderung von atmungsdepressionen | |
KR890700125A (ko) | 신규 벤즈이미다졸 유도체, 그 제조방법 및 이 화합물을 함유하는 제약 조성물 | |
ES2062610T3 (es) | Compuesto diarilico anti-ateroesclerotico. | |
DK1079849T3 (da) | Anvendelse af HMG-proteiner til fremstilling af lægemidler med cytotoksisk virkning | |
TR200000737T2 (tr) | İkame edilmiş kroman türevleri. | |
DE69512929D1 (de) | Salze von aminoalkoholen und diese enthaltende pharmazeutische zusammensetzungen | |
PT862575E (pt) | Novos derivados de geranilgeranilo processo para a sua preparacao e composicoes farmaceuticas relacionadas | |
FI913034A0 (fi) | Foerening med magsyrainhiberande effekt och foerfarande foer dess framstaellning. | |
DK370586D0 (da) | N-(4-piperidyl)benzamid-forbindelser, 1-substituerede 4-aminopiperidiner til anvendelse som udgangsmateriale ved deres fremstilling og farmaceutiske praeparater | |
PT87535A (pt) | Process for the preparation of novel anf peptide derivatives and of pharmaceutical compositions containing the same | |
SE9403389D0 (sv) | Pharmaceutical composition containing derivattves of sex hormones | |
EE03803B1 (et) | a-amino- ja tsüklopentaan-ß-aminohapet(-happeid) ja/või nende derivaate sisaldavad segud ja dipeptiidid, dipeptiidide valmistamismeetod ning nimetatud segusid ja/või dipeptiide sisaldavad ravimid | |
HUP9701293A2 (hu) | Új, kellemetlen íztől mentes sók és ezeket tartalmazó gyógyszerkészítmények | |
EE04095B1 (et) | Ketoliidide ja nende farmatseutiliselt vastuvõetavate soolade kasutamine farmatseutiliste kompositsioonide valmistamiseks | |
CO4910113A1 (es) | Composiciones farmaceuticas estabilizadas, a base de quinu- pristina y de dalfopristina y su preparacion | |
MY104088A (en) | Peptide-drugs compositions containing (alpha)-aminoboroic acid derivatives. | |
NO913644D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive aminosyrederivater. | |
EE9400182A (et) | Peptiidühendid, nende kasutamine, valmistamismeetod ja farmatseutiline segu |